© 2025 MJH Life Sciences™ , Patient Care Online – Primary Care News and Clinical Resources. All rights reserved.
Primary Care Training Boosts LARC Uptake and Long-Term Retention: Daily Dose
Patient Care brings primary care clinicians a lot of medical news every day—it’s easy to miss an important study. The Daily Dose provides a concise summary of one of the website's leading stories you may not have seen.
On October 14, 2025, we reported on findings from a study published in the American Journal of Obstetrics and Gynecology that was designed to assess whether the ACCORd (Australian Contraceptive ChOice pRoject) trial intervention resulted in sustained long-acting reversible contraception (LARC) use and decreased unplanned pregnancies.
The study
Researchers conducted a longitudinal 3-year follow-up study of the original ACCORd cluster randomized controlled trial. Included in the follow-up study were women seen by the intervention group of clinicians ACCORd family physicians who had completed a survey 12 months after LARC insertion. The primary outcome was continuation of LARC versus non-LARC methods; secondary outcomes included contraceptive method choice, satisfaction with the choice, and rates of unintended pregnancy and abortion.
The findings
LARC uptake and continuation. At 3 years after intervention, 41% of women in the intervention group continued using LARC, compared to 28% in usual care.
OC continuation. The overall rate of continuation for LARC methods (66%) was significantly higher than for non-LARC methods (55%; P =.027).
Unintended Pregnancy. Women in the intervention group experienced significantly fewer unintended pregnancies (3.1%) compared to the control group (6.3%; Odds Ratio 0.38).
Abortion Rate. Women in the intervention group also experienced significantly fewer abortions (0.9%) compared to the control group (3.6%; Odds Ratio 0.10).
Satisfaction. Satisfaction with the contraceptive method was reported as higher among LARC users compared to oral contraceptive pill users.